Ondansetron

Ondansetron works by blocking serotonin (5-HT3) receptors at two critical locations in the vomiting reflex pathway ^[1][2].

Nausea and vomiting are triggered when enterochromaffin cells in the small intestine release large amounts of serotonin in response to toxic stimuli such as chemotherapy drugs, radiation, or anesthetics ^[2]. This released serotonin activates 5-HT3 receptors on vagal afferent nerve terminals in the GI tract, which transmit signals to the vomiting center in the brainstem (the nucleus tractus solitarius and the area postrema/chemoreceptor trigger zone) ^[3].

Ondansetron blocks 5-HT3 receptors at both sites: 1. Peripheral blockade — on vagal nerve terminals in the GI tract, preventing the serotonin signal from being transmitted to the brain ^[2] 2. Central blockade — at the chemoreceptor trigger zone and nucleus tractus solitarius in the brainstem, blocking the processing of emetic signals that do reach the CNS ^[3]

This dual peripheral and central mechanism makes ondansetron one of the most effective antiemetics available, particularly for chemotherapy-induced nausea and vomiting (CINV), where serotonin release from damaged intestinal cells is the primary trigger ^[2]. Ondansetron is most effective against acute CINV (occurring within 24 hours of chemotherapy) and less effective against delayed CINV (24-120 hours), for which NK1 receptor antagonists (aprepitant) are better suited ^[4].

Ondansetron is generally very well tolerated with a favorable side effect profile compared to older antiemetics like metoclopramide and prochlorperazine ^[1].

For chemotherapy, ondansetron is typically given as a pre-treatment dose (oral or IV) 30 minutes before chemotherapy begins. You may receive additional doses during and after treatment depending on the regimen.

For post-operative nausea and vomiting, a single dose is often given at the end of surgery.

The orally disintegrating tablet (ODT) dissolves on the tongue in seconds and can be taken without water — particularly helpful when actively nauseated ^[1]. Despite dissolving on the tongue, the drug is absorbed in the GI tract, not sublingually.

Common side effects include headache (the most common, ~10%), mild constipation, and fatigue. Unlike older antiemetics, ondansetron does not cause significant sedation or extrapyramidal symptoms (involuntary movements), making it much better tolerated ^[1].

For nausea during pregnancy, ondansetron is widely used off-label and appears safe based on large population studies, though the FDA has not specifically approved it for this indication ^[6].

Food: Ondansetron can be taken with or without food ^[1]. Food does not significantly affect absorption. The ODT (orally disintegrating tablet) can be taken without water.

Alcohol: Ondansetron does not have a significant interaction with alcohol. However, alcohol may worsen nausea, which counteracts the purpose of antiemetic therapy. Avoid alcohol during acute nausea episodes.

Ginger: Some patients combine ondansetron with ginger (supplements or tea) for additional antiemetic effect. There is some evidence supporting ginger for nausea, and no known interaction with ondansetron ^[7].

Hydration: Patients with active nausea/vomiting should focus on maintaining hydration. Small, frequent sips of clear fluids are better tolerated than large volumes. If unable to tolerate oral fluids, IV hydration may be needed.

Chemotherapy-Induced Nausea/Vomiting (CINV): - Highly emetogenic chemo: 24 mg orally or 0.15 mg/kg IV (max 16 mg) as part of a multi-drug antiemetic regimen ^[1] - Moderately emetogenic chemo: 8 mg orally 30 min before chemo, then 8 mg 8 hours after first dose, then 8 mg BID for 1-2 days ^[1]

Radiation-Induced Nausea/Vomiting: 8 mg orally 1-2 hours before radiation, then 8 mg every 8 hours as needed ^[1].

Post-Operative Nausea/Vomiting (PONV): - Prevention: 4 mg IV at end of surgery (before extubation) ^[1] - Treatment: 4 mg IV as needed

Off-label — Pregnancy Nausea: 4 mg orally every 8 hours as needed. Some guidelines suggest starting with 4 mg BID ^[6].

Off-label — Gastroenteritis (pediatric): 0.15 mg/kg (max 4 mg) single oral dose to facilitate oral rehydration ^[8].

Pediatric (6 months-18 years): Weight-based dosing varies by indication. CINV: 0.15 mg/kg IV (max 16 mg single dose) ^[1].

Hepatic Impairment: Severe impairment (Child-Pugh C): maximum 8 mg/day ^[1].

Maximum single IV dose: 16 mg (32 mg removed due to QT risk) ^[5].

ODT Administration: Place on tongue, allow to dissolve (few seconds), then swallow with saliva. Do not try to push through the foil backing — peel the foil.

Generic ondansetron is widely available and very affordable. A supply of 10 tablets (4 mg or 8 mg) costs approximately $5-15 at most pharmacies ^[9].

Cost-saving strategies: - Generic is standard: Brand-name Zofran is no longer commonly stocked. Generic ondansetron (tablets, ODT, oral solution) is FDA "AB" rated and essentially universal - $4 generic lists: Ondansetron 4 mg and 8 mg tablets are included on many pharmacy discount programs - ODT vs. regular tablets: Generic ODT is slightly more expensive but offers the convenience of no water needed — valuable for patients who are actively vomiting - GoodRx coupons: Can reduce costs to $4-10 for typical supplies - Ask about as-needed prescribing: For anticipated nausea (chemotherapy days, post-surgery), having a small supply on hand avoids emergency pharmacy visits - Oral solution for children: Generic ondansetron oral solution is available and affordable for pediatric dosing

Pregnancy: Ondansetron is widely used off-label for nausea and vomiting of pregnancy (morning sickness) and hyperemesis gravidarum ^[6]. Large population studies (>1 million pregnancies) have been generally reassuring, with no clear increase in major birth defects ^[10]. A 2019 Danish study raised concern about a small increased risk of cardiac malformations with first-trimester exposure, but subsequent studies and meta-analyses have not consistently confirmed this finding ^[6].

Current practice: Many obstetricians prescribe ondansetron as a second-line antiemetic after vitamin B6/doxylamine (Diclegis/Bonjesta) fails to control symptoms. ACOG does not specifically recommend for or against ondansetron in pregnancy.

Breastfeeding: Limited data available. Ondansetron is excreted in animal milk. Given its short half-life and widespread use, the risk to the nursing infant is likely low ^[11]. Some clinicians recommend it when maternal benefit is clear.

Pediatric Use: Ondansetron is FDA-approved in children 6 months and older. It is extensively used off-label in emergency departments to control vomiting from gastroenteritis to facilitate oral rehydration ^[8].

Generic ondansetron has been available since 2006 and is now the standard product dispensed at all pharmacies. Brand-name Zofran is rarely stocked or prescribed.

Generic ondansetron is available in multiple formulations: - Tablets: 4 mg, 8 mg, 24 mg - Orally disintegrating tablets (ODT): 4 mg, 8 mg - Oral solution: 4 mg/5 mL - Injectable: 2 mg/mL (for hospital/clinic use)

All are FDA "AB" rated as therapeutically equivalent to the corresponding Zofran formulations. The ODT formulation is particularly convenient and widely appreciated by patients.